House bill introduced to require insurance coverage for Alzheimer's biomarker testing
/ 1 min read
Table of Contents
Representative [Name not provided in source] introduced a bill in the House that would change how health insurance covers tests used to identify Alzheimer’s disease.
Why it matters: If passed, this would move biomarker testing from an out-of-pocket expense or a coverage uncertainty to a standard covered benefit for many people.
Who it affects
- People with Alzheimer’s disease or those seeking a diagnosis
This information comes from Congress.gov regarding a House bill; please consult the official text before relying on this information for medical or financial decisions.
Agency: House
Source: Congress.gov — read the official document